Response of a mouse fibrosarcoma to withaferin A and radiation

Ravindra Kamath, B. S Satish Rao, P. Uma Devi

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

The in-vivo growth response of a transplantable mouse fibrosarcoma to withaferin A, a plant steroidal lactone, with or without local gamma radiation, was studied. Solid tumours were obtained by injecting 5 x 105 tumour cells on the dorsal skin of adult Swiss albino mice. Tumours of 100 ± 10 mm3 were treated with 10-60 mg kg-1 withaferin A with or without local exposure to 30 Gy gamma radiation. In another experiment tumour bearing mice were given 40 or 60 mg kg-1 withaferin A intraperitoneally, orally or intramuscularly to study the influence of route of administration. Tumour response was assessed by the tumour volume doubling time (VDT), growth delay (GD), complete response (complete regression with no regrowth at the primary site) and partial response (≥ 50% regression from the treated volume) over 120 days. Withaferin A (10-60 mg kg-1) produced a dose-dependent linear increase in VDT and GD. This increase was significant up to a dose of 40 mg kg-1. At 40 mg kg-1, the intraperitoneal route gave the maximum tumour response. The effectiveness of the oral route could be increased by increasing the dose. Radiation alone produced a 33% complete and 33% partial response and enhanced VDT significantly compared with control. Injection of 10-40 mg kg-1 withaferin A followed by radiation produced a further drug dose-dependent increase in VDT, GD and total response. The results indicate that withaferin A could be useful in the radiotherapy of solid tumours and a dose of 40 mg kg-1 appears to be optimum for single administration.

Original languageEnglish
Pages (from-to)287-291
Number of pages5
JournalPharmacy and Pharmacology Communications
Volume5
Issue number4
Publication statusPublished - 1999

Fingerprint

Fibrosarcoma
Radiation
Neoplasms
Gamma Rays
Growth
Radiation Dosage
Lactones
withaferin A
Tumor Burden
Radiotherapy
Skin
Injections
Pharmaceutical Preparations

All Science Journal Classification (ASJC) codes

  • Pharmacology
  • Pharmaceutical Science

Cite this

@article{d5e012f9b2c34e82afdbd010064088b0,
title = "Response of a mouse fibrosarcoma to withaferin A and radiation",
abstract = "The in-vivo growth response of a transplantable mouse fibrosarcoma to withaferin A, a plant steroidal lactone, with or without local gamma radiation, was studied. Solid tumours were obtained by injecting 5 x 105 tumour cells on the dorsal skin of adult Swiss albino mice. Tumours of 100 ± 10 mm3 were treated with 10-60 mg kg-1 withaferin A with or without local exposure to 30 Gy gamma radiation. In another experiment tumour bearing mice were given 40 or 60 mg kg-1 withaferin A intraperitoneally, orally or intramuscularly to study the influence of route of administration. Tumour response was assessed by the tumour volume doubling time (VDT), growth delay (GD), complete response (complete regression with no regrowth at the primary site) and partial response (≥ 50{\%} regression from the treated volume) over 120 days. Withaferin A (10-60 mg kg-1) produced a dose-dependent linear increase in VDT and GD. This increase was significant up to a dose of 40 mg kg-1. At 40 mg kg-1, the intraperitoneal route gave the maximum tumour response. The effectiveness of the oral route could be increased by increasing the dose. Radiation alone produced a 33{\%} complete and 33{\%} partial response and enhanced VDT significantly compared with control. Injection of 10-40 mg kg-1 withaferin A followed by radiation produced a further drug dose-dependent increase in VDT, GD and total response. The results indicate that withaferin A could be useful in the radiotherapy of solid tumours and a dose of 40 mg kg-1 appears to be optimum for single administration.",
author = "Ravindra Kamath and Rao, {B. S Satish} and {Uma Devi}, P.",
year = "1999",
language = "English",
volume = "5",
pages = "287--291",
journal = "Journal of Pharmacy and Pharmacology",
issn = "0022-3573",
publisher = "Pharmaceutical Press",
number = "4",

}

Response of a mouse fibrosarcoma to withaferin A and radiation. / Kamath, Ravindra; Rao, B. S Satish; Uma Devi, P.

In: Pharmacy and Pharmacology Communications, Vol. 5, No. 4, 1999, p. 287-291.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Response of a mouse fibrosarcoma to withaferin A and radiation

AU - Kamath, Ravindra

AU - Rao, B. S Satish

AU - Uma Devi, P.

PY - 1999

Y1 - 1999

N2 - The in-vivo growth response of a transplantable mouse fibrosarcoma to withaferin A, a plant steroidal lactone, with or without local gamma radiation, was studied. Solid tumours were obtained by injecting 5 x 105 tumour cells on the dorsal skin of adult Swiss albino mice. Tumours of 100 ± 10 mm3 were treated with 10-60 mg kg-1 withaferin A with or without local exposure to 30 Gy gamma radiation. In another experiment tumour bearing mice were given 40 or 60 mg kg-1 withaferin A intraperitoneally, orally or intramuscularly to study the influence of route of administration. Tumour response was assessed by the tumour volume doubling time (VDT), growth delay (GD), complete response (complete regression with no regrowth at the primary site) and partial response (≥ 50% regression from the treated volume) over 120 days. Withaferin A (10-60 mg kg-1) produced a dose-dependent linear increase in VDT and GD. This increase was significant up to a dose of 40 mg kg-1. At 40 mg kg-1, the intraperitoneal route gave the maximum tumour response. The effectiveness of the oral route could be increased by increasing the dose. Radiation alone produced a 33% complete and 33% partial response and enhanced VDT significantly compared with control. Injection of 10-40 mg kg-1 withaferin A followed by radiation produced a further drug dose-dependent increase in VDT, GD and total response. The results indicate that withaferin A could be useful in the radiotherapy of solid tumours and a dose of 40 mg kg-1 appears to be optimum for single administration.

AB - The in-vivo growth response of a transplantable mouse fibrosarcoma to withaferin A, a plant steroidal lactone, with or without local gamma radiation, was studied. Solid tumours were obtained by injecting 5 x 105 tumour cells on the dorsal skin of adult Swiss albino mice. Tumours of 100 ± 10 mm3 were treated with 10-60 mg kg-1 withaferin A with or without local exposure to 30 Gy gamma radiation. In another experiment tumour bearing mice were given 40 or 60 mg kg-1 withaferin A intraperitoneally, orally or intramuscularly to study the influence of route of administration. Tumour response was assessed by the tumour volume doubling time (VDT), growth delay (GD), complete response (complete regression with no regrowth at the primary site) and partial response (≥ 50% regression from the treated volume) over 120 days. Withaferin A (10-60 mg kg-1) produced a dose-dependent linear increase in VDT and GD. This increase was significant up to a dose of 40 mg kg-1. At 40 mg kg-1, the intraperitoneal route gave the maximum tumour response. The effectiveness of the oral route could be increased by increasing the dose. Radiation alone produced a 33% complete and 33% partial response and enhanced VDT significantly compared with control. Injection of 10-40 mg kg-1 withaferin A followed by radiation produced a further drug dose-dependent increase in VDT, GD and total response. The results indicate that withaferin A could be useful in the radiotherapy of solid tumours and a dose of 40 mg kg-1 appears to be optimum for single administration.

UR - http://www.scopus.com/inward/record.url?scp=0345620906&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0345620906&partnerID=8YFLogxK

M3 - Article

VL - 5

SP - 287

EP - 291

JO - Journal of Pharmacy and Pharmacology

JF - Journal of Pharmacy and Pharmacology

SN - 0022-3573

IS - 4

ER -